Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024
Novavax (Nasdaq: NVAX) has announced it will report its second quarter 2024 financial results and operational highlights on August 8, 2024 at 8:30 a.m. Eastern Time. The company, which focuses on advancing protein-based vaccines with its Matrix-M™ adjuvant, will host a conference call and webcast for this purpose. Participants can join via phone or webcast, with registration available through a provided URL. The call will be accessible domestically at (800) 836-8184 and internationally at (+1) (646) 357-8785. A replay will be available from 11:30 a.m. ET on August 8 until August 15, 2024, with the webcast replay extending to September 8, 2024.
Novavax (Nasdaq: NVAX) ha annunciato che presenterà i suoi risultati finanziari del secondo trimestre 2024 e i punti salienti operativi il 8 agosto 2024 alle 8:30 ora orientale. L'azienda, che si concentra sullo sviluppo di vaccini a base di proteine con il suo adiuvante Matrix-M™, terrà una conferenza telefonica e un webcast a tale scopo. I partecipanti possono unirsi tramite telefono o webcast, con registrazione disponibile tramite un URL fornito. La chiamata sarà accessibile a livello nazionale al numero (800) 836-8184 e a livello internazionale al (+1) (646) 357-8785. Una registrazione sarà disponibile dalle 11:30 ET dell'8 agosto fino al 15 agosto 2024, con la registrazione del webcast che si estenderà fino all'8 settembre 2024.
Novavax (Nasdaq: NVAX) ha anunciado que informará sobre sus resultados financieros del segundo trimestre de 2024 y los aspectos destacados operativos el 8 de agosto de 2024 a las 8:30 a.m., hora del Este. La empresa, que se centra en el avance de las vacunas a base de proteínas con su adyuvante Matrix-M™, realizará una conferencia telefónica y un webcast para este propósito. Los participantes pueden unirse por teléfono o por webcast, con registro disponible a través de una URL proporcionada. La llamada será accesible a nivel nacional al (800) 836-8184 y a nivel internacional al (+1) (646) 357-8785. Una repetición estará disponible desde las 11:30 a.m. ET del 8 de agosto hasta el 15 de agosto de 2024, con la repetición del webcast que se extenderá hasta el 8 de septiembre de 2024.
Novavax(Nasdaq: NVAX)는 2024년 2분기 재무 결과 및 운영 핵심 사항을 2024년 8월 8일 오전 8시 30분(동부 표준시)에 발표할 것이라고 발표했습니다. 단백질 기반 백신을 정진하는 것을 중심으로 하는 이 회사는 Matrix-M™ 보조제를 활용하여 이를 위한 전화 회의 및 웹캐스트를 개최할 예정입니다. 참가자는 제공된 URL을 통해 전화 또는 웹캐스트로 참여할 수 있습니다. 국내에서는 (800) 836-8184 번호로, 국제적으로는 (+1) (646) 357-8785 번호로 전화 회의에 접속할 수 있습니다. 8월 8일 오전 11시 30분 ET부터 2024년 8월 15일까지 녹음된 전화 회의에 접근할 수 있으며, 웹캐스트 녹음은 2024년 9월 8일까지 제공됩니다.
Novavax (Nasdaq: NVAX) a annoncé qu'il présentera ses résultats financiers du deuxième trimestre 2024 et ses points saillants opérationnels le 8 août 2024 à 8h30, heure de l'Est. L'entreprise, qui se concentre sur le développement de vaccins à base de protéines avec son adjuvant Matrix-M™, organisera une conférence téléphonique et un webinaire à cette fin. Les participants peuvent se joindre par téléphone ou par webinaire, avec une inscription disponible via une URL fournie. L'appel sera accessible nationalement au (800) 836-8184 et internationalement au (+1) (646) 357-8785. Une rediffusion sera disponible à partir de 11h30 ET le 8 août jusqu'au 15 août 2024, avec la rediffusion du webinaire s'étendant jusqu'au 8 septembre 2024.
Novavax (Nasdaq: NVAX) hat bekannt gegeben, dass es am 8. August 2024 um 8:30 Uhr Eastern Time seine finanziellen Ergebnisse für das zweite Quartal 2024 sowie betriebliche Highlights präsentieren wird. Das Unternehmen, das sich auf die Entwicklung von proteinbasierten Impfstoffen mit seinem Matrix-M™ Adjuvans konzentriert, wird zu diesem Zweck eine Telefonkonferenz und einen Webcast abhalten. Teilnehmer können telefonisch oder per Webcast teilnehmen, wobei eine Registrierung über eine bereitgestellte URL möglich ist. Die Konferenz wird national unter (800) 836-8184 und international unter (+1) (646) 357-8785 erreichbar sein. Eine Wiederholung wird ab 11:30 Uhr ET am 8. August bis zum 15. August 2024 verfügbar sein, während die Webcast-Wiederholung bis zum 8. September 2024 reicht.
- None.
- None.
Conference call details: | |
Date: | August 8, 2024 |
Time: | 8:30 a.m. |
URL to register phone: | |
Dial-in number: | (800) 836-8184 (Domestic) or |
(+1) (646) 357-8785 (International) | |
Webcast: |
- Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
- Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
- To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.
Replay details: | |
Date: | Available starting at 11:30 a.m. ET, August 8, 2024, until 11:59 p.m. |
Dial-in number: | (888) 660-6345 (Domestic) or |
(+1) (646) 517-4150 (International) | |
Passcode: | 52500# |
Webcast: | ir.novavax.com/events, until September 8, 2024 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in
Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-and-operational-highlights-on-august-8-2024-302212235.html
SOURCE Novavax, Inc.
FAQ
When will Novavax (NVAX) report its Q2 2024 financial results?
How can investors join Novavax's (NVAX) Q2 2024 earnings call?
Until when will the replay of Novavax's (NVAX) Q2 2024 earnings call be available?
What is the focus of Novavax's (NVAX) business?
